| Lung cancer treatment advances in 2022 F Abu Rous, EK Singhi, A Sridhar, MS Faisal, A Desai Cancer investigation 41 (1), 12-24, 2023 | 35 | 2023 |
| Breast cancer in geriatric patients: current landscape and future prospects H Abdel-Razeq, F Abu Rous, F Abuhijla, N Abdel-Razeq, S Edaily Clinical Interventions in Aging, 1445-1460, 2022 | 17 | 2022 |
| Chylothorax: complication attributed to dasatinib use A Al-Abcha, MH Iftikhar, FA Rous, H Laird-Fick BMJ Case Reports CP 12 (12), e231653, 2019 | 14 | 2019 |
| Pembrolizumab in combination with chemotherapy in patients with ERBB2-mutated non-small cell lung cancer F Abu Rous, R Gutta, P Li, B Halmos, S Gadgeel Targeted Oncology 17 (2), 187-192, 2022 | 5 | 2022 |
| When thyroid labs do not add up, physicians should ask patients about biotin supplements MS Lundin, A Alratroot, FA Rous, S Aldasouqi BMJ Case Reports CP 13 (3), e231337, 2020 | 4 | 2020 |
| Challenges faced by J-1 international medical graduates (IMGS) during Covid-19 pandemic F Abu Rous, I Riano Cancer investigation 41 (3), 249-252, 2023 | 3 | 2023 |
| Emerging biomarkers in immune oncology to guide lung cancer management H Safa, F Abu Rous, N Belani, H Borghaei, S Gadgeel, B Halmos Targeted Oncology 18 (1), 25-49, 2023 | 3 | 2023 |
| Abiraterone acetate for treatment of ectopic Cushing syndrome caused by ACTH-producing neuroendocrine tumor: a case report R Chacko, NH Abdel-Razeq, FA Rous, R Loutfi Journal of Gastrointestinal Oncology 13 (5), 2626, 2022 | 3 | 2022 |
| Profiling changes in metabolism and the immune microenvironment in lung tumorigenesis D Zhang, AS Leal, FA Rous, KT Liby Annals of Translational Medicine 7 (Suppl 3), 2019 | 3 | 2019 |
| Antithrombin supplementation in adults with acute lymphoblastic leukemia (ALL) following asparaginase therapy: a meta-analysis O Mosalem, M Mujer, FA Rous, CE Cole Blood 136, 20, 2020 | 2 | 2020 |
| Pulmonary embolism as the primary presentation of IgA vasculitis O Mosalem, NH Garcilazo, Y Saleh, FA Rous BMJ Case Reports CP 13 (8), e235884, 2020 | 2 | 2020 |
| Targeting Oncogenic Driver Mutations in Lung Cancer M Lee, FA Rous, A Borczuk, S Liu, S Gadgeel, B Halmos Elements in Molecular Oncology, 2023 | 1 | 2023 |
| Pyomyositis as an unusual presentation of colonic adenocarcinoma O Mosalem, FA Rous, A Al-Abcha, S Kherallah, J Burch The Permanente Journal 25, 2021 | 1 | 2021 |
| Bilateral breast masses as a presentation for T-cell acute lymphoblastic leukaemia O Mosalem, FA Rous, A Elshafie, D Isaac BMJ Case Reports CP 13 (8), e236263, 2020 | 1 | 2020 |
| Diffuse Alveolar Hemorrhage Secondary to Direct Oral Anticoagulants: A Systematic Review of Reported Cases F Abu Rous, A al-Abcha, L El-Khatib, S Shrotriya, P Dhakal Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 1 | 2018 |
| PP01. 114 Outcomes of Patients Diagnosed with Lung Cancer after COVID-19 Infection Z Al-Saheli, O Ammari, L Albusoul, FA Rous, S Gadgeel Journal of Thoracic Oncology 19 (7), e49, 2024 | | 2024 |
| PP01. 69 Atypical Lung Carcinoids with EML4-ALK Fusion and Responses to ALK Inhibitors S Waliany, YP Hung, FA Rous, A Do, J Peterson, C Meservey, ... Journal of Thoracic Oncology 19 (7), e32-e33, 2024 | | 2024 |
| PP01. 107 Patient Characteristics and Treatment Patterns in Biomarker Selected Early Non-Small Cell Lung Cancer FA Rous, J Sussell, CN Kochounian, Q Zhang, T Majda, D Sheinson, ... Journal of Thoracic Oncology 19 (7), e47, 2024 | | 2024 |
| Real-world outcomes in patients with biomarker-selected early-stage non-small cell lung cancer. F Abu Rous, J Sussell, C Ngiam, Q Zhang, T Majda, D Sheinson, S Ogale, ... Journal of Clinical Oncology 42 (16_suppl), 11156-11156, 2024 | | 2024 |
| Clinical Trials for Patients With Cancer FA Rous, A Desai, EK Singhi JAMA oncology 10 (3), 416-416, 2024 | | 2024 |
Osama MosalemMayo clinic在 mayo.edu 的电子邮件经过验证
